医学
肺活量测定
支气管扩张剂
乙酰甲胆碱
哮喘
预测值
麻醉
内科学
心脏病学
呼吸道疾病
肺
作者
Pino Jm,Francisco García‐Rio,Carlos Martín de Argila de Prados,Rodolfo Álvarez-Sala,Salvador Díaz Lobato,C. Villasante,J. Villamor
出处
期刊:PubMed
[National Institutes of Health]
日期:1996-03-01
卷期号:24 (2): 54-7
被引量:6
摘要
To determine the accuracy of the peak expiratory flow (PEF) as an alternative parameter to the forced expiratory volume at first second (FEV1) in the bronchodynamic tests.We studied 84 patients, 53 males and 31 females, with average age 46 +/- 13 years, as clinic suspects of bronchial asthma. PEF was determined with a "mini-Wright peak flow meter" and a spirometry was obtained. Based on the results, 44 subjects were classified under group 1 (FEV1/FVC < 70% and FEV1 < 80% of theoretic value) and subjected to a bronchodilator test. While in group 2 subjects (normal spirometry), a methacholine challenge was performed. During each procedure, PEF readings were obtained before FEV1 determination. The usefulness of the PEF for the diagnosis of reversibility or bronchial obstruction with respect to the FEV1 was assessed in both groups.In the bronchodilator tests, a cut-off point was found for the increase in the PEF > 18%, which showed a sensitivity of 85%, specificity of 79%, positive predictive value of 77% and negative predictive value of 86%, with respect to an increase in the FEV1 > 15%. In the methacholine challenge, a decrease in the PEF > 12% only achieved a sensitivity of 74% and specificity of 71%.Peak expiratory flow may be an useful parameter in bronchodilator tests. However, it should not be used in methacholine challenge.
科研通智能强力驱动
Strongly Powered by AbleSci AI